Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.6K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Activated Macrophages Promote TNF-α-Associated Tumor Cell Necroptosis in Pituitary Apoplexy Through the PIEZO1-NFATC2/REL Axis.

International journal of molecular sciences·2026
Same author

Research on the Formability of 2A12 Aluminum Alloy Sheet During High-Speed Hot Gas Bulging.

Materials (Basel, Switzerland)·2026
Same author

Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.

Cells·2026
Same author

Specific depletion of TIGIT<sup>high</sup> CD226<sup>-</sup> clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting.

Journal for immunotherapy of cancer·2026
Same author

Greater efficiency of the double-bending method compared with conventional endoscopic submucosal dissection for the treatment of submucosal tumors of the gastric fundus.

Surgical endoscopy·2026
Same author

Tailored ZnCu Conductive MOF as a Floating-Gate in Carbon Nanotube Network FET NH<sub>3</sub> Sensors.

ACS sensors·2025

相关实验视频

Updated: Jan 9, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

MMFF-DDI:用于药物相互作用事件预测的多模式融合框架,使用对比学习.

Jian Zhong, Haochen Zhao, Guihua Duan

    IEEE transactions on computational biology and bioinformatics
    |December 1, 2025
    PubMed
    概括

    预测药物相互作用事件 (DDIEs) 对于安全的组合疗法至关重要. 我们的MMFF-DDI框架使用多模式学习来提高现有和新药的预测准确性.

    科学领域:

    • 药理学 药理学是指药理学的学科.
    • 计算化学的计算化学
    • 人工智能在药物发现中的作用

    背景情况:

    • 准确预测药物相互作用事件 (DDIEs) 对于优化组合疗法和提高药物安全至关重要.
    • 现有的预测方法往往难以整合局部化学子结构和3D几何特征,因为它们依赖于有限的表示.

    研究的目的:

    • 开发一个先进的多模式融合框架,MMFF-DDI,以改善药物相互作用事件 (DDIE) 预测.
    • 通过共同捕捉各种分子特征来克服当前方法的局限性.

    主要方法:

    • MMFF-DDI采用多模式方法,从摩根指纹,正规的SMILES和3D分子图中提取药物表征.
    • 使用注意力增强自编码器,MolFormer编码器和等价图形神经网络 (EGNN) 来进行特征提取.
    • 包含一个对比的多模式集成子模块,用于基于对齐的学习,增强跨模式的一致性和特征融合.

    主要成果:

    • 在预测现有药物的DDIE方面,MMFF-DDI显著优于现有方法,在宏观F1方面提高了7.87%,在宏观精度方面提高了7.99%.
    • 对于新药DDIE预测,MMFF-DDI超越了竞争方法,分别提高了8.06%和12.79%的宏观F1和宏观精度.
    • 可视化和案例研究证实了该框架的实际适用性和卓越的预测性能.

    更多相关视频

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K

    相关实验视频

    Last Updated: Jan 9, 2026

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K

    结论:

    • MMFF-DDI通过利用多模式数据和对比学习,为预测药物相互作用事件提供了强大而有效的解决方案.
    • 拟议的框架提高了DDIE预测的准确性和可靠性,有助于更安全,更有效的药物治疗.
    • 源代码是公开的,这有助于在这个关键领域进行进一步的研究和开发.